NCT06163391View on ClinicalTrials.gov

A Study to Assess Safety and Efficacy of SOT201 in Patients With Advanced/Metastatic Cancer

PHASE1RecruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

May 1, 2024

Primary Completion Date

October 31, 2026

Study Completion Date

October 31, 2026

Conditions
Advanced Solid TumorMetastatic Solid Tumor
Interventions
DRUG

SOT201

intravenous infusion

Trial Locations (7)

1070

RECRUITING

Institut Jules Bordet, Anderlecht

2650

RECRUITING

Universitair Ziekenhuis Antwerpen (UZA), Edegem

77030

RECRUITING

MD Anderson Cancer Center, Houston

94805

NOT_YET_RECRUITING

Institut Gustave Roussy, Paris

Unknown

RECRUITING

Masarykův Onkologický Ústav, Brno

779 00

WITHDRAWN

Fakultni Nemocnice Olomouc (FNOL) - Onkologicka Klinika, Olomouc

08035

RECRUITING

Hospital Universitari Vall d'Hebron - Vall d'Hebron Institut d'Oncologia (VHIO), Barcelona

All Listed Sponsors
lead

SOTIO Biotech AG

INDUSTRY

NCT06163391 - A Study to Assess Safety and Efficacy of SOT201 in Patients With Advanced/Metastatic Cancer | Biotech Hunter | Biotech Hunter